Funding for this research was provided by:
Korea Health Industry Development Institute
Ministry of Health and Welfare (HI14C1277)
Ministry of Science ICT and Future Planning
Chong Kun Dang Pharmaceutical Corp
Received: 6 May 2020
Accepted: 2 July 2020
First Online: 25 July 2020
Ethics approval and consent to participate
: Informed consent was obtained from all participants in accordance with the Declaration of Helsinki. The study was approved by the Institutional Review Board at Seoul National University Hospital (IRB No: H-1507-108-690).
: Not applicable.
: Authors declare no competing interest.